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ABSTRACT 
Fragment C is the C-terminal domain of the heavy chain of tetanus toxin that can promote the immune response 
against the lethal dose of this toxin. Therefore, this portion can be considered as a candidate vaccine against 
tetanus infection, which occurs by Clostridium tetani. The present study aimed to compare the expression of 
tetanus toxin fragment C in Escherichia coli  BL21 (DE3) pLysS cells having a high tolerance to toxins between 
two different expression vectors, namely pET22b and pET28a, using the sodium dodecyl sulfate polyacrylamide 
gel electrophoresis and western blot analyses. After DNA extraction from Harvard CN49205 strain of C. tetani, 
the gene of interest was amplified using polymerase chain reaction, and then sequenced and cloned into the 
expression vectors of pET22b and pET28a, transformed into competent BL21 (DE3) pLysS cells, and finally 
expressed using an optimized protocol. The cells were induced with isopropyl β-D-1-thiogalactopyranoside 
(IPTG) at four different incubation temperatures (i.e., 37, 33, 30, and 25 °C) and three different incubation times 
(i.e., 1, 2, and 3 h). Although the SDS-PAGE and western blot analyses confirmed the expression of the 
recombinant fragment C (r-fragment C) ligated into both of the expression vectors, pET28a showed a higher r-
fragment C expression level than the other vector (38.66 mg/L versus 32.33 mg/L, P<0.05). An optimal 
expression condition was acquired 3 h after 1 mM IPTG induction at 25 °C. The results demonstrated that E. 
coli BL21 (DE3) pLysS as an expression host in combination with pET-28a as an expression vector was a more 
compatible expression system to express the fragment C of tetanus toxin, compared to E. coli BL21 (DE3) 
pLysS/pET-22b expression system. Overall, these results may represent an opportunity to improve the 
expression system for the production of tetanus toxin vaccine using recombinant protein strategy. 
Keywords: Clostridium tetani, Fragment C, pET22b expression vector, pET28a expression vector, E. coli BL21 
(DE3) pLysS 
 
La forte expression du fragment C de la toxine tétanique dans Escherichia coli  
Résumé: Le fragment C'est le domaine C-terminal de la chaîne lourde de la toxine tétanique. Ce dernier favorisé 
la réponse immunitaire contre la dose létale de cette toxine et peut donc être considéré comme un candidat 
potentiel pour le vaccin contre l'infection tétanique causée par Clostridium tetani. Dans cette étude, l'expression 
du fragment C de la toxine tétanique dans des cellules BL21 (DE3) pLysS d'E. coli ayant une tolérance élevée 
aux toxines a été comparée en utilisant deux vecteurs d'expression différents, pET22b et pET28a, par SDS-
PAGE et western blot. Après l’extraction de l'ADN de la souche Harvard CN49205 de C. tetani, le gène d'intérêt 
a été amplifié par PCR, séquencé, cloné dans les vecteurs d'expression, pET22b et pET28a, transformé dans des 
cellules compétentes BL21 (DE3) pLysS et enfin exprimé selon un protocole optimisé. Les cellules ont été 
induites avec IPTG à quatre températures d'incubation différentes (37, 33, 30 et 25° C) et trois temps 
d'incubation différents (1 à 3 h). Bien que l'expression du fragment recombinant C (fragment C) ligaturé dans les 
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INTRODUCTION 
Tetanus is an infection caused by Clostridium tetani, 
which is an obligate anaerobic spore-forming bacterium 
(Gil et al., 2001). Tetanus toxin is a potent neurotoxin 
that is intracellularly synthesized by C. tetani as a 
single 150 kDa polypeptide chain. Following cell lysis, 
the toxin is released into the medium and cleaved by 
endogenous proteases generating a 50 kDa N-terminal 
light chain (fragment A) disulfide bonded to a 100 kDa 
C-terminal heavy chain (fragments B and C) 
(Bruggemann and Gottschalk, 2004). Fragment C, the 
50 kDa C-terminal portion of the heavy chain, has 
ganglioside (Helting and Zwisler, 1977) and protein 
(Schiavo et al., 1991) binding activities in the tissues of 
neural origin. These gangliosides are considered to be 
potential relevant eukaryotic cell receptors (Herreros et 
al., 2000). Fragment C is completely nontoxic in 
animals, whereas fragment B retains some residual 
toxicity at high doses (Helting et al., 1977). Fragment C 
has been demonstrated to retain the ganglioside binding 
activity of intact tetanus toxin (Morris et al., 1980). 
Therefore, purified fragment C is used to successfully 
immunize the animals against tetanus. This indicates 
that the entire molecule is not essential for protection 
(Helting and Nau, 1984). It seems that this fragment 
can be used as a novel efficient vaccine without any 
neurotoxicity. In some studies, the recombinant 
fragment C (r-fragment C) was expressed alone or in 
fusion with other antigens on different strains of 
Escherichia coli (Fairweather and Lyness, 1986; 
Makoff et al., 1989; Halpern et al., 1990; Ribas et al., 
2000; Yousefi et al., 2013), Salmonella (Chatfield et 
al., 1992), Lactobacillus (Maassen et al., 1999), 
Bordetella (Stevenson and Roberts, 2004), yeast cells 
(Romanos et al., 1991), and cultured insect cells 
(Charles et al., 1991), which in some cases resulted in 
the induction of protective antibodies against tetanus 
toxin. However, each of these studies encountered 
some deficiencies, such as the presence of several 
fortuitous polyadenylation sites within r-fragment C in 
S. cerevisiae (Romanos et al., 1991), presence of 
glycosylation sites in S. cerevisiae and Pichia pastoris, 
which would result in inactive antigen (Romanos et al., 
1991), phenotypic alterations, including chlorotic 
phenotype and male sterility in tobacco leaves 
(Tregoning et al., 2003), low ganglioside binding 
activity of r-fragment C of baculovirus expression 
system (Charles et al., 1991), and ethical issues 
regarding live vector vaccines. E. coli expression 
system also has some problems, such as low expression 
level and low solubility rates of r-fragment C. Despite 
the many attempts made to improve the expression 
level and solubility rate of r-fragment C (Fairweather et 
al., 1986; Makoff et al., 1989; Halpern et al., 1990; 
Ribas et al., 2000; Wang et al., 2008; Yousefi et al., 
2013), the suggested solutions in this area have not 
been analyzed yet. It seems that some limitations in the 
deux vecteurs d'expression ait été confirmée par les analyses SDS-PAGE et western blot, pET28a a montré une 
expression plus élevée du fragment r C comparé à pET22b (38,66 mg / l contre 32,33 mg / l, p <0,5). La 
condition optimale d'expression a été obtenueà 5° C, IPTG 1 mM, et 3 h après l’induction de l’IPTG. Ces 
résultats ont démontré que l’hôte d'expression E. coli BL21 (DE3) pLysS en combinaison avec le vecteur deux 
vecteurs d'expression ait été confirmée par les analyses SDS-PAGE et western blot, pET28a a montré une 
expression plus élevée du fragment r C comparé à pET22b (38,66 mg / l contre 32,33 mg / l, p <0,5). La 
condition optimale d'expression a été obtenueà 5° C, IPTG 1 mM, et 3 h après l’induction de l’IPTG. Ces 
résultats ont démontré que l’hôte d'expression E. coli BL21(DE3) pLysS en combinaison avec le vecteur 
d'expression pET-28a représentait le système d'expression le plus compatible pour exprimer le fragment C de la 
toxine tétanique. Dans l’ensemble, ces résultats montrent qu’il est possible d’améliorer la production de vaccin 
contre la toxine tétanique à base de protéines recombinantes en optimisant leur système d'expression. 
Mots-clés: Clostridium tetani, Fragment C, vecteur d'expression pET22b, vecteur d'expression de pET28a, E. 
coli BL21 (DE3) pLysS 
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expression level of r-fragment C are related to the 
probable toxicity of this antigen to E. coli as the 
expression host. On the other hand, the low solubility 
rate of this protein is probably due to its high tendency 
to form inclusion bodies in overproduction condition 
(Miyake et al., 2007). The two major factors that 
reduce the production rate of the recombinant proteins, 
such as r-fragment C, are the formation of inclusion 
bodies resulting in a low solubility rate (Miyake et al., 
2007) and degradation by lon and ompT outer 
membrane proteases (Goff and Goldberg; Grodberg 
and Dunn, 1988). Another problem in this area is the 
limitations related to the traditional expression method 
(Sambrook and Russell, 2001). Therefore, it could be 
highly desirable to investigate the expression of r-
fragment C in the BL21 (DE3) pLysS strain of E. coli 
containing a pLysS plasmid with a high tolerance to 
toxins and lacking lon and ompT outer membrane 
proteases and an expression vector with a strong 
promoter using a modified protocol. With this 
background in mind, the present study, aimed to 
investigate the expression of the gene encoding 
fragment C of tetanus toxin in E. coli BL21 (DE3) 
pLysS using pET22b and pET28a vectors. In addition, 
a comparative study was performed between pET22b 
and pET28a expression vectors in order to determine 
the plasmid that is more compatible with E.coli BL21 
(DE3) pLysS cells for expressing r-fragment C. We 
also used a recently-optimized expression method in 
our laboratory (Bahreini et al., 2014) for the 
overexpression of r-fragment C. Moreover, different 
temperature and time levels were analyzed in order to 
determine an optimal expression condition, which is an 
important factor in the overexpression and 
overproduction of a recombinant protein. 
MATERIALS AND METHODS 
Polymerase chain reaction, cloning, and DNA 
sequencing. Total DNA was extracted from Harvard 
CN49205 strain of C. tetani using the High Pure PCR 
Template Preparation Kit (Roche Diagnostic, 
Germany). The gene encoding fragment C of tetanus 
toxin was amplified using specific primers, including 
5'GGAATTCCATATGAAAAATCTGGATTGTTGG
GT3' as forward primer containing NdeI restriction site 
(shown as underlined letters) as well as 
5'CCGCTCGAGTTAATCATTTGTCCATCCTT3' and 
5'CCCAAGCTTTTAATCATTTGTCCATCCTT3' as 
reverse primers, including XhoI and HindIII restriction 
sites, respectively (shown as underlined letters), and 
stop codon (shown as italic and bold letters). Based on 
the kind of the reverse primer (XhoI or HindIII), two 
different PCRs with similar conditions were performed. 
The PCRs were carried out with 300 ng of total DNA 
in a final volume of 50 µl containing 10X PCR buffer, 
0.2 mM dNTP (Roche Diagnostics, Germany), 1 
unit/reaction of Pfu DNA polymerase (Fermentas, 
Russia) combined with 0.5 unit/reaction of Taq DNA 
polymerase (Fermentas, Russia), 1.5 mM MgCl2, 10 
pmol/reaction of each forward and reverse primers, and 
double-distilled H2O up to the total volume of 50 µl. 
Both of the PCR reactions were performed by a Gene 
Cycler (Bio-Rad, USA) with the following thermo-
cycling profile: initial denaturation at 95 °C for 5 min, 
followed by 5 cycles of 95 °C for 1 min, 50 °C for 1 
min, and 72 °C for 1 min, and then 30 cycles of 95 °C 
for 1 min, 57 °C for 1 min, and 72 °C for 1 min. The 
final extension was 10 min at 72 °C. The PCR products 
were visualized by electrophoresis on 1% agarose gel. 
Subsequently, they were purified from agarose gel by 
the High Pure PCR Template Preparation Kit and 
ligated into pTZ57R/T cloning vector (Fermentas, 
Germany). The ligated mixtures were transformed into 
E. coli DH5α (Invitrogen, USA) competent cells using 
the heat shock method (Sambrook and Russell, 2001). 
Then, the recombinant transformed colonies were 
screened on lysogeny broth (LB) agar media containing 
100 µg/mL ampicillin, 20 mg/mL5-bromo-4-chloro-3-
indolyl-β-D-galactopyranoside, and 0.1 M IPTG. Two 
different recombinant pTZtetc plasmids were extracted 
using the High Pure Plasmid Isolation Kit (Roche 
Diagnostic, Germany). Then, the sequencing was 
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performed in both directions using T7 promoter and 
M13 (-20) primers, a BigDye Terminator Cycle 
Sequencing Reaction Kit (Applied Biosystems, 
Canada), and an ABI 3730 XL DNA Analyzer 
(BioNeer, South Korea). The obtained nucleotide 
sequence of the gene encoding fragment C was 
analyzed using BioEdit software (Hall, 1999). 
Subcloning into expression vectors and gene 
expression. One of the two distinctive recombinant 
pTZtetc plasmids harboring NdeI and XhoI restriction 
sites was ligated into pET22b expression vector 
(Novagen, USA) at NdeI and XhoI cloning sites. The 
other recombinant pTZtetc plasmid containing NdeI 
and HindIII restriction sites was ligated into pET28a 
expression vector (Novagen, USA) at NdeI and HindIII 
cloning sites. In order to express r-fragment C, initially, 
the recombinant pET22b and pET28a expression 
vectors were separately transformed into E. coli BL21 
(DE3) pLysS competent cells using the heat shock 
method. Subsequently, the mixtures were cultured on 
(LB) agar plates containing 50 µg/mL ampicillin and 
34 µg/mL chloramphenicol obtained from recombinant 
E. coli BL21 (DE3) pLysS transformed with pET22b, 
as well as 30 µg/mL kanamycin and 34 µg/mL 
chloramphenicol obtained from recombinant E. coli 
BL21 (DE3) pLysS transformed with pET28a. In order 
to overexpress the gene of interest, we used an 
optimized expression method reported in our previous 
study (Bahreini et al., 2014) rather than the traditional 
method described by Sambrook and Russell (2001). To 
this end, three steps were considered for the bacterial 
growth at 37oC in a shaking incubator at 200 rpm 
(Bahreini et al., 2014). At the first step, a single colony 
from each of the two recombinant transformed E. coli 
BL21 (DE3) pLysS cells, cultured on the LB plates, 
was inoculated in 5 mL of LB broth supplemented with 
1% w/v glucose (50 µg/mL ampicillin and 30 µg/mL 
kanamycin obtained from pET22b and pET28a, 
respectively). The resulting mixtures were incubated 
for 7 h. At the second step, the first-step media were 
transferred into 100 mL of LB broth (1% w/v glucose), 
containing 300 µg/mL ampicillin and 200 µg/mL 
kanamycin obtained from pET22b and pET28a, 
respectively, and incubated overnight. At the third step, 
the overnight media were exchanged by centrifuging 
(1200 g, 4 °C for 5 min). Subsequently, the fresh LB 
media (1% w/v glucose), containing 50 µg/mL 
ampicillin and 30 µg/mL kanamycin obtained from 
pET22b and pET28a, respectively, were added to the 
bacterial pellets and diluted until obtaining an optical 
density(OD) of 10 at 600 nm. The last media were 
incubated for 75 min in order to adapt bacteria to the 
fresh media until adding inducer and beginning protein 
expression. Afterwards, each medium was incubated 
with 1 mM IPTG at four different incubation 
temperatures (i.e., 37, 33, 30, and 25 °C) and three 
different incubation times (i.e., 1 to 3 h after IPTG 
induction) in order to determine the optimal condition 
for the expression of r-fragment C.  
Immunoblotting. Prior to IPTG induction and 1, 2, 
and 3 h after that, sampling from each medium was 
performed, and the cells from each sample were 
immediately harvested by centrifuging at 10,000 g and 
4 °C for 5 min. Each of the harvested bacterial cell 
pellets was diluted and lysed in 5X sample buffer 
(Laemmli, 1970). The total protein concentration in cell 
lysate was determined by the Bradford Protein Assay 
Reagent Kit (Bio-Rad, USA). For the SDS-PAGE 
analysis, the protein samples were loaded on a 10×10 
cm and 12.5% SDS-PAGE gel following the method 
described by Laemmli (1970). The mixtures were 
electrophoresed using Protean II xi cells (Bio-Rad, 
USA) in electrophoresis buffer (Laemmli, 1970) for 24 
h at 30 V. The gel was stained with coomassie brilliant 
blue R-250. Finally, the specific band of r-fragment C 
protein was cut out from the gel, and its concentration 
was evaluated using Bradford assay for both of the 
expression vectors. For western blot, fractioned 
proteins were transferred into polyvinylidene 
fluoride (PVDF) membranes (Roche Diagnostic, 
Germany) using an Electro Blot System (Bio-Rad, 
USA) in a transferring buffer (pH=8.3), containing 25 
mM Tris, 192 mM glycine, and 15% methanol. The 
solution was kept overnight at 20 V and 4°C, blocked 
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with 5%  bovine serum albumin (BSA) with gentle 
rocking at room temperature for 1.5 h, and washed for 
three times in TBST (pH=7.2), containing 20 mM Tris-
HCl, 150 mM CaCl2, and 0.05% W/V Tween 20. 
Subsequently, the membrane was probed with horse 
anti-tetanus toxin polyclonal antibody (Razi Vaccine 
and Serum Research Institute, Karaj, Iran) (1:1000 
dilution in TBST) using gentle rocking at ambient 
temperature for 1.5 h. The membrane was then washed 
four times with TBST and incubated with horse radish 
peroxidase-conjugated Anti-Goat IgG (Abcam, UK) 
(1:1000 dilution in TBST) using gentle rocking at room 
temperature for 1.5 h. After washing the membrane 
again, the color was developed using 3'-
Diaminobenzidine.  
Statistical analysis. The concentrations of total cell 
protein and r-fragment C were determined through the 
estimation of the mean and standard deviation. 
Additionally, the percent yield was calculated. The t-
test was used to analyze the differences between the 
two expression systems in terms of protein 
concentration. All data analysis was performed in SPSS 
software. P-value less than 0.05 was considered 
statistically significant.  
RESULTS 
Polymerase chain reaction, gene cloning, and 
DNA sequence analysis. Two different PCR products, 
both of which encoded the fragment C of tetanus toxin, 
were obtained using total DNA from C. tetani as a 
template and designed primers. The agarose gel 
electrophoresis of the two amplicons confirmed them to 
be ~ 1.4 kb in size (Figure 1). Both of the PCR 
products were then cloned into pTZ57R/T cloning 
vector. The recombinant constructs were verified by 
means of DNA sequencing and digestion using NdeI 
and XhoI restriction endonucleases producing one of 
the two amplicons (Figure 2a) and NdeI and HindIII 
restriction endonucleases generating the other one 
(Figure 2b). DNA sequence analysis confirmed both 
amplicons to be exactly 1356 bp in size as reported by 
the sequences of C.  tetani strain CN3911, a derivative 
of  Harvard strain (Fairweather and Lyness, 1986) and 
Massachusetts strain of C. tetani (Eisell et al., 1986). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2b. Electrophoresis on 
1% (w/v) agarose gel for the 
restriction enzyme digestion of 
the recombinant cloning vector 
(pTZ57R) using NdeI/XhoI, 
confirming the insertion of the 
gene encoding tetanus toxin 
fragment C into this vector. 
Lane 1: DNA size marker 1kb 
(Fermentase, Germany); lane 
2: single digestion product of 
recombinant pTZ57R using 
NdeI endonuclease; lane 3: 
double digestion products of 
recombinant pTZ57R using 
NdeI and XhoI. 
Figure 1. Electrophoresis on 
1% (w/v) agarose gel for two 
different polymerase chain 
reaction products, both 
encoding fragment C of 
tetanus toxin, verifying the 
amplification of the gene of 
interest. Lane 1: DNA size 
marker 1 kb (Fermentase, 
Germany). Lanes 2 and 3: 
polymerase chain reaction 
products of fragment C gene 
obtained by specific primers, 
including NdeI/XhoI and 
NdeI/HindIII restriction 
sites, respectively. 
Figure 2a. Electrophoresis on 
1% (w/v) agarose gel for two 
different polymerase chain 
reaction products, both 
encoding fragment C of 
tetanus toxin, verifying the 
amplification of the gene of 
interest. Lane 1: DNA size 
marker 1 kb (Fermentase, 
Germany). Lanes 2 and 3: 
polymerase chain reaction 
products of fragment C gene 
obtained by specific primers, 
including NdeI/XhoI and 
NdeI/HindIII restriction 
sites, respectively. 
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Based on the sequence analysis, in the two samples 
sequenced in the present study, no mutations or 
polymorphisms were found within the gene encoding 
fragment C obtained from Harvard CN49205 strain of 
C. tetani (DTP department, Razi Vaccine and Serum 
Research Institute, Karaj, Iran). The nucleotide 
sequence of tetanus toxin fragment C analyzed in the 
present study was deposited into the NCBI GenBank 
(GenBank ID: FJ917402). 
Construction of recombinant expression plasmids.  
Figure 3 displays a schematic representation of two 
recombinant pET22b and pET28a expression vectors 
designed by SnapGene software, version 2.8 
(www.snapgene.com). These two vectors both 
containing fragment C gene of C. tetani (Figure 3) were 
constructed in order to express the r-fragment C protein 
in E. coli BL21 (DE3) pLysS. The electrophoresis of 
the two recombinant expression vectors on agarose gel 
confirmed them to have a higher length than the non-
recombinant ones (~ 6.7 kb versus ~ 5.4 kb For the 
recombinant and non-recombinant pET22b, respectively, 
and ~ 6.6 kb versus ~ 5.3 kb in the recombinant and non-
recombinant pET28a, respectively) (Figures 2c and 2d). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Expression of r-fragment C. As shown in Figure 
4a, the r-fragment C was successfully expressed in E. 
coli BL21 (DE3) pLysS as the fusion and native 
proteins. The production of the recombinant protein 
was detectable after 1 h of IPTG induction and reached 
a maximal level after 3 h in both expression vectors. 
Furthermore, the high expression level of r-fragment C 
was achieved at the incubation temperature of 25 °C 
(Figure 4a). The expressed r-fragment C was either 
approximately 51.6 kDa as a native protein in pET22b 
vector or almost 54 kDa as a fusion protein in pET28a 
(Figure 4a). As shown in Table 1, no significant 
differences were observed between the two expression 
systems in terms of total soluble protein in cell lysate. 
However, Bradford analysis showed that the 
concentration of r-fragment C obtained by pET28a was 
higher than that obtain from pET22b (38.66 mg/L 
versus 32.33 mg/L, P<0.5) (Table 1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1. Mean of total soluble protein and recombinant fragment C 
concentrations in cell lysates and percentage of the yield obtained 
from the two expression vectors of pET28a and pET22b 
Protein source Expression vector  
 pET28a pET22b P-value 
Total soluble protein 
(mg/L) 
381.67±14.0 395.0±9.85 NS 
Recombinant-
fragment C (mg/L) 
32.33±3.05 38.66±2.08 P<0.5 
Yield (%) 8.5±0.5 9.8±0.4 P<0.5 
NS: not-significant, Note: The data presented in this table is related 
to the Escherichia coli cultures with log phase of “10” and 
expression condition of 25 °C, 1 mM IPTG, and 3 h IPTG 
induction. 
Western blot analysis. To detect the r-fragment C, a 
western blot assay was performed using anti-tetanus 
Figure 2c. Electrophoresis on 
1% (w/v) agarose gel for the 
restriction enzyme digestion of 
the recombinant and non-
recombinant expression vector 
(pET22b) using NdeI/XhoI, 
confirming the insertion of the 
gene encoding tetanus toxin 
fragment C into this vector. Lane 
1: DNA size marker 1kb 
(Fermentase, Germany); lane 2: 
double digestion product of non-
recombinant pET22b using NdeI 
and XhoI; lane 3: double 
digestion products of 
recombinant pET22b using 
NdeI and XhoI. 
 
Figure 2d. Electrophoresis on 
1% (w/v) agarose gel for the 
restriction enzyme digestion of 
the recombinant and non-
recombinant expression vector 
(pET28a) using NdeI/HindIII, 
confirming the insertion of the 
gene encoding tetanus toxin 
fragment C into this vector. 
Lane 1: DNA size marker 1kb 
(Fermentase, Germany); lane 
2: double digestion products 
of recombinant pET28a using 
NdeI and HindIII; lane 3: 
double digestion product of 
non-recombinant pET28a 
using NdeI and HindIII. 
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toxin-specific polyclonal antibody under reducing 
conditions.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3a. Schematic representation of the recombinant pET22b 
expression vector designed by SnapGene software version 2.8. The 
gene encoding fragment C of tetanus toxin was cloned into the 
NdeI/XhoI restriction sites of pET22b vector. 
Figure 3b. Schematic representation of the recombinant pET28a 
expression vector designed by SnapGene software version 2.8. The 
gene encoding fragment C of tetanus toxin was cloned into the 
NdeI/HindIII restriction sites of pET28a vector, in frame with the 6-
histidin tag and thrombin cleavage site in N-terminal proportion of 
pET28a. 
 
As shown in Figure 4b, the western blot by 
polyclonal horse antisera against r-fragment C of 
tetanus toxin resulted in the emergence of only one 
band on the membrane in both recombinant native 
(51.6 kDa) and fusion (54 kDa) proteins, representing 
that horse antibodies specifically bound to the r-
fragment C produced by both expression vectors, 
namely pET22b and pET28a. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4a. Analysis of total cell lysates of transformed E. coli 
BL21 (DE3) pLysS, containing recombinant pET22b or pET28a 
expression vectors by sodium dodecyl sulfate polyacrylamide (SDS-
PAGE) gel electrophoresis, confirming high expression level of 
recombinant fragment C of tetanus toxin. Samples of cell lysates 
including total protein content were collected at 24 h intervals after 
methanol induction, separated by 12.5% SDS-PAGE gel, and 
visualized by staining with coomassie blue R-250. Lane 1: negative 
control; lanes 2 and 7: total cell protein obtained from E. coli BL21 
(DE3) pLysS cells bearing the recombinant expression constructs in 
pET22b and pET28a, respectively, grown in the absence of 
isopropyl β-D-1-thiogalactopyranoside (IPTG); lane 3: protein 
molecular weight standards (Fermentas, Lithuania); lanes 4, 5, and 
6: the same as lane 2, but the samples were taken 1, 2, and 3 h after 
IPTG induction, respectively; lanes 8, 9, and 10: the same as lane 7, 
but the samples were taken 1, 2, and 3 h after IPTG induction, 
respectively.  
Figure 4b. Analysis of total cell lysates of transformed E. coli 
BL21 (DE3) pLysS, containing recombinant pET22b or pET28a 
expression vectors by western blot, confirming high purification of 
recombinant fragment C of tetanus toxin. Fractioned proteins were 
transferred from the SDS-PAGE gel onto a polyvinylidene 
difluoride (PVDF) membrane, and a single band representing 
recombinant fragment C was detected in both recombinant native 
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(51.6 kDa) and fusion (54 kDa) forms; lane 1: schematic 
representation of a broad-range protein size marker (Fermentas, 
Lithuania); lanes 2 and 3: PVDF membranes probed with total cell 
protein from E. coli BL21 (DE3) pLysS cells containing the 
recombinant pET28a and pET22b, respectively; lane 4: negative 
control. 
DISCUSSION 
There are many reports confirming the antigenicity of 
fragment C of tetanus toxin, since it has been identified 
as an immunodominant (Francis et al., 2004; Carlton et 
al., 2008) and nontoxic (Helting and Zwisler, 1977; 
Helting and Nau, 1984) antigen. Therefore, some 
research teams have used this fragment to produce a 
recombinant vaccine against tetanus (Maassen et al., 
1999; Ribas et al., 2000; Stevenson and Roberts, 2004).  
In the present study, we successfully expressed the r-
fragment C of tetanus toxin in E. coli regarding the 
production of recombinant subunit vaccine against 
tetanus toxin. Although several studies have hitherto 
succeeded to clone and express the fragment C of 
tetanus toxin, there are still some problems in the 
industrial production of this antigen. A problem 
occurring in the overproduction process of many 
proteins by a recombinant protein expression system is 
the limitations of the traditional, widely used standard 
system for protein expression in the shaking flask 
cultures described by Sambrook and Russell (2001). In 
this regard, some solutions to this problem are 
available, which were used in the present study. Based 
on the traditional expression methods, the recombinant 
protein synthesis is induced, when the (OD600) reaches 
to 0.6, at a point about the middle of the exponential 
growth. Such low cell densities produce a low yield 
value. As a result, a large culture volume is required for 
high protein production. On the other hand, the 
expression of recombinant plasmid gene is a 
biochemical pathway, decreasing the specific rate of 
population growth and cell density owing to two 
factors. Firstly, this pathway in bacteria is a long 
process; therefore, nutrient depletion, accumulation of 
waste and toxic metabolites, and inhibitory compounds 
in the medium will provide antigrowth conditions, such 
as plasmid loss (Hannig and Makrides, 1998), limited 
availability of dissolved oxygen (DO), and increased 
CO2 levels, which cause significant reduction of 
medium pH (Khushoo et al., 2004). Therefore, under 
such circumstances, high cell densities cannot be 
reached. Secondly, for the high processivity of T7 RNA 
polymerase and IPTG induction, most of the 
transcription and translation machinery of the cell 
might be employed for recombinant protein expression, 
resulting in the reduction of bacterial growth rate and 
cell density (Sambrook and Russell, 2001). The low 
cell density often causes a low protein production.  To 
overcome these problems, in the present study, we used 
a recently-optimized protocol (Bahreini et al., 2014), 
which was set in our laboratory using ASNase II as a 
recombinant protein model rather than the traditional 
protocol (Sambrook and Russell, 2001). This modified 
method resulted in a higher number of plasmid copies 
in each cell, and subsequently a higher copy number of 
the fragment C gene per cell using a high antibiotic 
concentration (i.e., 200 and 300 µg/mL) before the 
induction time, which would lead to a significant 
increase in protein expression per cell (Bahreini et al., 
2014). Furthermore, a fresh medium with a very higher 
initial cell density (OD600=10 versus OD600=0.6) at 
induction time was provided using a three step-culture, 
the third step of which included exchanging the 
overnight medium by centrifuging, adding fresh LB 
medium to the bacterial pellet, and diluting until 
reaching a high cell density. As fragment C is part of a 
toxic protein, we supposed that its basal levels may 
prevent the full establishment of the plasmid carrying 
its codding gene in E. coli strains, which will result in 
the incomplete expression of this gene in this 
bacterium. On the other hand, one of the major factors 
reducing the overproduction of recombinant proteins, 
such as r-fragment C, is protein degradation by lon and 
ompT outer membrane proteases (Goff and Goldberg; 
Grodberg and Dunn, 1988). One way of providing 
additional stability to the target genes is to express 
them in the host strains containing a compatible 
chloramphenicol-resistant plasmid that provides a small 
amount of T7 lysozyme, a natural inhibitor of T7 RNA 
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polymerase (Studier, 1991). In the present study, BL21 
(DE3) pLysS strain of E. coli, a high-stringency 
expression host, which has the pLysS plasmid, was 
used. This plasmid confers resistance to 
chloramphenicol.  The lysozyme produced by this 
plasmid does not interfere with the transformation of 
the cells containing it and has no negative effect on the 
growth rate. The presence of pLysS increases the 
tolerance of expression host in the plasmids with toxic 
inserts, and also has the further advantage of facilitating 
the preparation of the cell extracts. This strain is also 
deficient in the lon protease and lacks the ompT outer 
membrane protease. Therefore, fragment C should be 
more stable in BL21 (DE3) pLysS than in the host 
strains containing the mentioned proteases. An 
alternative approach to increase the stability of the 
target gene is to use a vector that contains a T7lac 
promoter ((Dubendorf and Studier, 1991; Studier, 
1991). In this regard, in the present study, two different 
expression vectors, namely pET-28a and pET-22b, 
both containing T7lac promoter were used. These 
plasmids contain a lac operator sequence just 
downstream of T7 promoter. They also carry the 
natural promoter and coding sequence for the lacI so 
that the T7lac and lacI promoters diverge. When this 
type of vector is used in DE3 lysogens to express the r-
fragment C, the lac repressor acts both at lacUV5 
promoter in the host chromosome to repress the 
transcription of the T7 RNA polymerase gene by the 
host polymerase and at the T7lac promoter in the vector 
to block the transcription of the target gene by T7 RNA 
polymerase (Dubendorf and Studier, 1991; Studier, 
1991). The results of the present study revealed that the 
employment of BL21 (DE3) pLysS strain of E. coli as 
an expression host and pET-28a and pET-22b as 
expression vectors could overcome the probable toxic 
effects of fragment C on the establishment of the 
plasmid and the subsequent expression level of its 
encoding gene. These results showed that the recently 
optimized protocol set in our laboratory for high 
expression level of ASNase II (Bahreini et al., 2014) 
could be also applied for the expression of tetanus toxin 
fragment C. Another important factor reducing the 
overproduction of the recombinant proteins is the low 
solubility rate (Gerday et al., 1990). It should be 
mentioned that in some cases, the overexpression of a 
special protein does not result in its overproduction. 
The high-level expression of both heterologous and 
host proteins in E. coli is often accompanied by the 
formation of inclusion bodies, which are irreversible 
aggregates mainly consisting of the overexpressed 
polypeptide (Ho et al., 1990). Proteins in form of 
inclusion bodies are insoluble agents resulting in low 
production rate. In this regard, the protein expression at 
low temperatures would be favorable to increase the 
overproduction of the proteins, which tend to form 
inclusion bodies. This is due to the fact that the 
formation of inclusion bodies is sometimes avoided by 
lowering the cultivation temperature (Vasina and 
Baneyx, 1996). When E. coli is used as the host, the 
cultivation temperature is sometimes decreased to 
suppress the formation of inclusion bodies (Miyake et 
al., 2007). A low-temperature expression system is also 
expected to alleviate the heat denaturation of proteins 
and would be suitable for the production of 
thermolabile proteins (Miyake et al., 2007). Protein 
expression at low temperatures is also useful for the 
production of the enzymes whose activities are harmful 
to the host cells, such as proteases that degrade the 
essential components of the host, because the enzyme 
activities can be suppressed by lowering the 
temperature (Miyake et al., 2007). In the present study, 
the transformants were induced with IPTG at four 
different incubation temperatures (i.e., 37, 33, 30, and 
25 °C) and three different incubation times (i.e., 1-3 h). 
The optimal expression condition, in this study, was 
acquired at 25 °C, 1 mM IPTG, and 3 h after IPTG 
induction (Figure 4a), which was desirable to suppress 
the formation of the inclusion bodies, resulting from the 
overproduction of r-fragment C in E. coli expression 
system. Ribas et al. (2000) similarly reported the 
optimal expression condition at 1 mM IPTG and 3 h 
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after IPTG induction. In contrast with our results, 
(Yousefi et al., 2013) reported the optimal expression 
time of 8 h after IPTG induction. The transformed E. 
coli BL21 (DE3) pLysS with pET-28a produced a 
fusion protein (~54 kDa) consisting of a 6-histidin tag 
and a thrombin cleavage site in N-terminal proportion, 
and the cells transformed with pET-22b produced a 
protein (~ 51.6 kDa) in a native form. The presence of a 
histidin tag in the expressed protein facilitates its 
purification via one-step metal-affinity chromatography. 
On the other hand, as any additional amino acid 
sequence may affect the structure, spatial conformation, 
and the subsequent function of the native protein, they 
should be removed from the native protein sequence in 
order to be used in the clinical trial testing and final 
product manufacturing. In this regard, the presence of 
thrombin cleavage site (N-Leu-Val-Pro-Arg-Gly-Ser-
C) within the expressed protein produced in the present 
study enabled us to cleave the 6-histidin tag from 
protein sequence in the future studies. Although the 
western blot analysis confirmed the expression of both 
recombinant native and fusion fragments C, the yield 
obtained by pET28a was higher than that of pET22b 
(9.8% versus 8.5%, P<0.5). Therefore, it seems that 
BL21 (DE3) pLysS, as an expression host, was more 
compatible with pET28a expression vector than with 
pET22b to express the r-fragment C. The results of the 
present study revealed the occurrence of no mutations 
or polymorphisms during gene amplification or cloning 
procedure, which is a desirable characteristic for a 
bacterial strain to be applied as a vaccinal strain.   
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